Portola Pharmaceuticals Overview

Life ScienceCompany

Was Portola Pharmaceuticals formerly PE-backed?

Yes. Portola Pharmaceuticals was formerly owned by 1 private investor.

Where is Portola Pharmaceuticals headquartered?

Portola Pharmaceuticals is headquartered in South San Francisco, California.

What is Portola Pharmaceuticals’ revenue?

Portola Pharmaceuticals disclosed revenue of 117M USD for 2019 and 40M USD for 2018.

How many employees does Portola Pharmaceuticals have?

Portola Pharmaceuticals has 324 employees.

What sector is Portola Pharmaceuticals in?

Portola Pharmaceuticals is a life science company.

When was Portola Pharmaceuticals founded?

Portola Pharmaceuticals was founded in 2003.

Portola Pharmaceuticals, Inc.

270 East Grand Avenue,
South San Francisco, California 94080
United States,
(650) 246-7000
www.portola.com

Portola Pharmaceuticals, Inc. is a biopharmaceutical company, discovers and develops therapeutics for cardiovascular and autoimmune diseases. Portola Pharmaceuticals was founded in 2003 and is based in South San Francisco, California.



Try Mergr Free — See This and 221,398+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.